🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

3,067 results for “Hospital” Clear

  1. Selective serotonin reuptake inhibitor (SSRI)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Anxiety Depression

    approved small molecule active

    1 trial

  2. Sertraline

    The First People's Hospital of Lianyungang

    Efficacy, Team

    approved small molecule completed

    1 trial

  3. Sertraline Hydrochloride

    The First People's Hospital of Lianyungang

    COVID-19 Vaccine Adverse Reaction

    approved small molecule completed

    1 trial

  4. Sevelamer

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Degenerative Heart Valve Disease

    approved small molecule active

    1 trial

  5. Sevoflurane

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Intra-abdominal and Intrapelvic Surgery

    approved small molecule completed

    1 trial

  6. Sevoflurane

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Middle Aged Patients

    approved small molecule completed

    1 trial

  7. Shenfu Injection

    The First People's Hospital of Lianyungang

    Septic Shock

    approved small molecule active

    2 trials

  8. Shenfu Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Septic Cardiomyopathy

    approved small molecule active

    1 trial

  9. Shenfu Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Myocardial Infarction

    approved small molecule completed

    1 trial

  10. Shenlingcao Oral Liquid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Carcinoma, Non-Small-Cell Lung

    approved small molecule completed

    1 trial

  11. Shexiang Baoxin pill

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Disease(CAD)

    approved small molecule active

    1 trial

  12. Simethicone

    Hospital Authority, Hong Kong

    Colonoscopy

    approved small molecule completed

    1 trial

  13. Simvastatin

    Hospital Authority, Hong Kong

    Obesity

    approved small molecule active

    1 trial

  14. Sirolimus

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Antiphospholipid (aPL)-Positive

    approved small molecule active

    1 trial

  15. Skin stretching device (SSD)

    The First People's Hospital of Lianyungang

    Trauma

    approved other active

    1 trial

  16. Sodium Bicarbonate Ringer's Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Septic Shock

    approved small molecule active

    1 trial

  17. SomaKit TOC 40 micrograms kit for radiopharmaceutical preparation

    Ningbo Cancer Hospital

    Gastroenteropancreatic neuroendocrine tumors

    approved small molecule active

    1 trial

  18. Songling Xuemaikang Capsules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypertension,Essential

    approved small molecule active

    1 trial

  19. Standard BP control

    The First People's Hospital of Lianyungang

    Hypertension

    approved small molecule active

    1 trial

  20. Statin

    The First People's Hospital of Lianyungang

    Acute Coronary Syndrome

    approved small molecule active

    1 trial

  21. Succinylcholine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    the Effect of Succinylcholine on Barrier Pressure

    approved small molecule completed

    1 trial

  22. Sufentanil

    The First People's Hospital of Lianyungang

    Arteriovenous Malformation

    approved small molecule active

    1 trial

  23. TPO-RAs

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Primary Immune Thrombocytopenia (ITP)

    approved small molecule active

    1 trial

  24. Tacrolimus sustained-release capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Renal Transplant Recipients

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources